Incyte

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.

CEO

William J. Meury

CEOWilliam J. Meury

Employees

2,617

Employees2,617

Headquarters

Wilmington, Delaware

HeadquartersWilmington, Delaware

Founded

1991

Founded1991

Employees

2,617

Employees2,617

INCY Key Statistics

Market cap

13.48B

Market cap13.48B

Price-Earnings ratio

211.17

Price-Earnings ratio211.17

Dividend yield

—

Dividend yield—

Average volume

1.57M

Average volume1.57M

High today

$70.15

High today$70.15

Low today

$68.21

Low today$68.21

Open price

$69.88

Open price$69.88

Volume

1.48M

Volume1.48M

52 Week high

$83.95

52 Week high$83.95

52 Week low

$53.56

52 Week low$53.56

INCY News

TipRanks 17h

Incyte’s Phase 3 Study on Povorcitinib: A Potential Game-Changer for Hidradenitis Suppurativa

Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium a...

TipRanks 4d

Insider Moves: Constellation, Pure, Appian, Box, Incyte

Insiders have been trading these 5 stocks: ((STZ)), ((PSTG)), ((APPN)), ((BOX)) and ((INCY)). Here is a breakdown of their recent trades and their value. Eleva...

TipRanks 5d

Incyte’s Phase 1 Study on INCB057643: A Potential Game-Changer in Myeloid Neoplasms Treatment

Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premiu...

Analyst ratings

48%

of 29 ratings

Buy

48.3%

Hold

48.3%

Sell

3.4%

More INCY News

Simply Wall St 7d

Don't Ignore The Insider Selling In Incyte

Some Incyte Corporation ( ) shareholders may be a little concerned to see that insider Barry Flannelly recently sold a substantial US$743k worth of stock at a p...

People also own

Based on the portfolios of people who own INCY. This list is generated using Robinhood data, and it’s not a recommendation.